Business · 12/03/2024Updated: 10/17/2026 · 1 min read
FDA Renews Pharmaceutical Science and Clinical Pharmacology Advisory Committee for 2 Years
The Food and Drug Administration (FDA) is renewing the Pharmaceutical Science and Clinical Pharmacology Advisory Committee for an additional 2 years, with a new charter set to expire on January 22, 2026.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →